Ap. Goldman et al., NITRIC-OXIDE IS SUPERIOR TO PROSTACYCLIN FOR PULMONARY-HYPERTENSION AFTER CARDIAC OPERATIONS, The Annals of thoracic surgery, 60(2), 1995, pp. 300-306
Background. Severe pulmonary hypertension is still a cause of morbidit
y and mortality in children after cardiac operations. The objective of
this study was to compare the vasodilator properties of inhaled nitri
c oxide, a novel pulmonary vasodilator, and intravenous prostacyclin i
n the treatment of severe postoperative pulmonary hypertension. Method
s. Thirteen children (aged 3 days to 12 months) with severe pulmonary
hypertension after cardiac operations were given inhaled nitric oxide
(20 ppm x 10 minutes) acid intravenous prostacyclin (20 ng.kg(-1).min(
-1) x 10 minutes) in a prospective, randomized cross-over study. Resul
ts. Both nitric oxide and prostacyclin resulted in a reduction in pulm
onary arterial pressure, although the mean pulmonary arterial pressure
was significantly lower during nitric oxide therapy (28.5 +/- 2.9 mm
Hg) than during prostacyclin therapy (35.4 +/- 2.1 mm Hg; p < 0.05). T
he mean pulmonary to systemic arterial pressure ratio was also signifi
cantly lower during nitric oxide than prostacylin administration (0.46
+/- 0.04 versus 0.68 +/- 0.05; p < 0.01), due mainly to only prostacy
clin lowering systemic blood pressure. Conclusions. Inhaled nitric oxi
de was a more effective and selective pulmonary vasodilator than prost
acyclin and should be considered as the preferred treatment for severe
postoperative pulmonary hypertension.